These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 300112
1. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses. Burton RC, Warner NL. J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112 [Abstract] [Full Text] [Related]
2. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice. Burton RC, Warner NL. J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529 [Abstract] [Full Text] [Related]
4. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas. Burton RC, Warner NL. Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633 [Abstract] [Full Text] [Related]
5. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens. Chism SE, Burton RC, Warner NL. J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560 [Abstract] [Full Text] [Related]
8. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors. Wagner H, Röllinghoff M. J Exp Med; 1973 Jul 01; 138(1):1-15. PubMed ID: 4541509 [Abstract] [Full Text] [Related]
10. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F, Jongeneel V, Cerottini JC, Brunner KT. Eur J Immunol; 1976 Nov 01; 6(11):823-9. PubMed ID: 187429 [Abstract] [Full Text] [Related]
11. Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11. Giorgi JV, Burton RC, Scott D, Warner NL. Int J Cancer; 1982 Jan 15; 29(1):119-26. PubMed ID: 6977499 [Abstract] [Full Text] [Related]
17. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens. Kedar E, Bonavida B. J Immunol; 1975 Nov 10; 115(5):1301-8. PubMed ID: 51889 [Abstract] [Full Text] [Related]
18. In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas. Burton RC, Warner NL. Br J Cancer; 1978 Feb 10; 37(2):159-70. PubMed ID: 75739 [Abstract] [Full Text] [Related]
19. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response. Rouse BT, Röllinghoff M, Warner NL. Eur J Immunol; 1973 Apr 10; 3(4):218-24. PubMed ID: 4541468 [No Abstract] [Full Text] [Related]
20. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses. Fujiwara H, Yoshioka T, Shima J, Kosugi A, Itoh K, Hamaoka T. J Immunol; 1986 Apr 01; 136(7):2715-9. PubMed ID: 3005417 [Abstract] [Full Text] [Related] Page: [Next] [New Search]